作者
AI Tsonis, P Zisimopoulou, K Lazaridis, J Tzartos, E Matsigkou, V Zouvelou, R Mantegazza, C Antozzi, F Andreetta, A Evoli, F Deymeer, G Saruhan-Direskeneli, Hacer Durmus, T Brenner, A Vaknin, S Berrih-Aknin, A Behin, T Sharshar, M De Baets, Mario Losen, P Martinez-Martinez, KA Kleopa, E Zamba-Papanicolaou, T Kyriakides, A Kostera-Pruszczyk, P Szczudlik, B Szyluk, D Lavrnic, I Basta, S Peric, C Tallaksen, A Maniaol, C Casasnovas Pons, J Pitha, M Jakubíkova, F Hanisch, SJ Tzartos
发表日期
2015/7/15
期刊
Journal of neuroimmunology
卷号
284
页码范围
10-17
出版商
Elsevier
简介
Seronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and understanding. We applied a cell based assay (CBA) for the detection of muscle specific kinase (MuSK) antibodies undetectable by radioimmunoassay. We tested 633 triple-seronegative MG patients' sera from 13 countries, detecting 13% as positive. MuSK antibodies were found, at significantly lower frequencies, in 1.9% of healthy controls and 5.1% of other neuroimmune disease patients, including multiple sclerosis and neuromyelitis optica. The clinical data of the newly diagnosed MuSK-MG patients are presented. 27% of ocular seronegative patients were MuSK antibody positive. Moreover, 23% had thymic hyperplasia suggesting that thymic abnormalities are more common than believed.
引用总数
201520162017201820192020202120222023202431016136977112
学术搜索中的文章